4-((Tert-butyldiphenylsilyl)oxy)cyclohexan-1-one, 98%, 1g

4-Bromo-3-fluoro-2-hydroxybenzoic acid, 97.0%, 1g

TERT-BUTYL 4-(6-CHLOROPYRAZIN-2-YL)PIPERIDINE-1-CARBOXYLATE, 95.0%, 1g

Methyl 6-fluoro-3-oxo-2,3-dihydro-1H-indene-5-carboxylate, 95.0%, 5g

2-Amino-4-chloro-5-iodobenzoic acid, 97%, 1g

1-Bromo-4-butylbenzene, 97.0%, 500g

3-chloro-N-(2,3-dimethylphenyl)propanamide, 95.0%, 1g

4-Bromocyclohexanone, 97%, 1g

4-Chloro-6-fluoro-8-methoxyquinoline-3-carbonitrile, 95%, 1g

(R)-Methyl 4-((3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate, 98%, 250mg

(2R,3R,4S,5R)-2-(4-Amino-5-bromo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 97.0%, 1g

Erbium foil 99.9% 0.1 x 25 x 25 mm 1 pc

3-(Piperidin-4-yl)benzo[d]oxazol-2(3H)-one hydrochloride, 95.0%, 1g